icon-    folder.gif   Conference Reports for NATAP  
 
  Conference on Retroviruses
and Opportunistic Infections (CROI)
February 13-16, 2017, Seattle WA
Back grey_arrow_rt.gif
 
 
 
Efficacy and Safety of Switching to E/C/F/TAF
in Virologically Suppressed Women
 
 
  Reported by Jules Levin
CROI 2017 Feb 14-16 Seattle, WA
 
WEBCAST: http://www.croiwebcasts.org/console/player/33375?mediaType=slideVideo&
 
Sally Hodder,1 Kathleen Squires,2 Cissy Kityo,3 Debbie Hagins,4 Anchalee Avihingsanon,5 Yulia Plotnikova,6 Shuping Jiang,7 Rima Kulkarni,7 Andrew Cheng,7 Huyen Cao7 1West Virginia Clinical & Translational Science Institute, Morgantown, WV; 2Thomas Jefferson University, Philadelphia, PA; 3Joint Clinical Research Centre, Kampala, Uganda; 4Georgia Dept of Public Health, Coastal Health District, Chatham Care Center, Savannah, GA;
5HIV Netherlands Australia Thailand Research Collaboration, The Thai Red Cross AIDS Research Centre, Bangkok, Thailand; 6Irkutsk Regional Center for Prevention and Control of AIDS and Infectious Diseases, Irkutsk, Russia; 7Gilead Sciences, Inc., Foster City, CA
 
144 Weeks TAF - CROI: Significant Efficacy and Long-term Safety Difference With TAF-Based STR in Naïve Adults - (02/16/17)

0224171

0224172

0224173

0224174